The CHG and alcohol scrub used led to less needleless connector contamination than just the alcohol scrub at a five-second scrub time, the study found.
“This study answers a previously unknown clinical question about the most efficacious antiseptic for disinfection of needleless access sites and also ideal prep times,” said Hudson Garrett, PhD, vice president of clinical affairs for PDI. “This study demonstrates the importance of targeted efforts to reduce contamination on needleless access sites and ensure evidence-based practices for disinfection of needleless access sites.”
According to an news release, PDI’s Prevantics Device Swab is the only CHG and alcohol swab on the market that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites before use.
More articles on infection prevention:
53 hospitals with the lowest pneumonia 30-day mortality rates
5 steps to temper, prevent Legionella outbreaks
9 statistics on healthcare professionals’ Ebola readiness
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.